company background image
524396 logo

Biofil Chemicals and Pharmaceuticals BSE:524396 Stock Report

Last Price

₹59.47

Market Cap

₹967.8m

7D

-7.0%

1Y

7.3%

Updated

22 Dec, 2024

Data

Company Financials

Biofil Chemicals and Pharmaceuticals Limited

BSE:524396 Stock Report

Market Cap: ₹967.8m

524396 Stock Overview

Manufactures and trades in pharmaceuticals in India. More details

524396 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Risk Analysis

Earnings have declined by 21.1% per year over past 5 years

Does not have a meaningful market cap (₹968M)

Does not have meaningful revenue (₹315M)


My Notes

Capture your thoughts, links and company narrative

Biofil Chemicals and Pharmaceuticals Limited Competitors

Vasundhara Rasayans

BSE:538634

₹947.6m

Mercury Laboratories

BSE:538964

₹1.1b

Panjon

BSE:526345

₹755.0m

Onyx Biotec

NSEI:ONYX

₹967.3m

Price History & Performance

Summary of share price highs, lows and changes for Biofil Chemicals and Pharmaceuticals
Historical stock prices
Current Share Price₹59.47
52 Week High₹92.00
52 Week Low₹53.50
Beta2.11
1 Month Change-0.25%
3 Month Change-29.25%
1 Year Change7.31%
3 Year Change-0.47%
5 Year Change284.17%
Change since IPO2,731.90%

Recent News & Updates

Recent updates

Shareholder Returns

524396IN PharmaceuticalsIN Market
7D-7.0%0.8%-4.2%
1Y7.3%39.7%19.1%

Return vs Industry: 524396 underperformed the Indian Pharmaceuticals industry which returned 39.7% over the past year.

Return vs Market: 524396 underperformed the Indian Market which returned 19.1% over the past year.

Price Volatility

Is 524396's price volatile compared to industry and market?
524396 volatility
524396 Average Weekly Movement6.4%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 524396 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 524396's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198526Ramesh Shahwww.biofilgroup.net

Biofil Chemicals and Pharmaceuticals Limited manufactures and trades in pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic drippers and caps for packing applications.

Biofil Chemicals and Pharmaceuticals Limited Fundamentals Summary

How do Biofil Chemicals and Pharmaceuticals's earnings and revenue compare to its market cap?
524396 fundamental statistics
Market cap₹967.80m
Earnings (TTM)₹5.36m
Revenue (TTM)₹314.53m

180.6x

P/E Ratio

3.1x

P/S Ratio

Is 524396 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524396 income statement (TTM)
Revenue₹314.53m
Cost of Revenue₹289.55m
Gross Profit₹24.98m
Other Expenses₹19.62m
Earnings₹5.36m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.33
Gross Margin7.94%
Net Profit Margin1.70%
Debt/Equity Ratio2.5%

How did 524396 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 07:12
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biofil Chemicals and Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution